GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Forian Inc (NAS:FORA) » Definitions » Revenue per Share

FORA (Forian) Revenue per Share : $0.63 (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Forian Revenue per Share?

Forian's revenue per share for the three months ended in Sep. 2024 was $0.15. Forian's revenue per share for the trailing twelve months (TTM) ended in Sep. 2024 was $0.63.

During the past 12 months, the average Revenue Per Share Growth Rate of Forian was 3.90% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 228.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Forian's Revenue per Share or its related term are showing as below:

FORA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 228   Med: 228   Max: 228
Current: 228

During the past 5 years, Forian's highest 3-Year average Revenue Per Share Growth Rate was 228.00% per year. The lowest was 228.00% per year. And the median was 228.00% per year.

FORA's 3-Year Revenue Growth Rate is ranked better than
99.83% of 601 companies
in the Healthcare Providers & Services industry
Industry Median: 10.3 vs FORA: 228.00

Forian Revenue per Share Historical Data

The historical data trend for Forian's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forian Revenue per Share Chart

Forian Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Revenue per Share
- 0.02 0.57 0.51 0.64

Forian Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.17 0.16 0.15 0.15

Competitive Comparison of Forian's Revenue per Share

For the Health Information Services subindustry, Forian's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Forian's PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Forian's PS Ratio distribution charts can be found below:

* The bar in red indicates where Forian's PS Ratio falls into.



Forian Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Forian's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )=Revenue (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=20.481/32.231
=0.64

Forian's Revenue Per Share for the quarter that ended in Sep. 2024 is calculated as

Revenue Per Share (Q: Sep. 2024 )=Revenue (Q: Sep. 2024 )/Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
=4.686/31.098
=0.15

Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Forian  (NAS:FORA) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Forian Revenue per Share Related Terms

Thank you for viewing the detailed overview of Forian's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Forian Business Description

Traded in Other Exchanges
N/A
Address
41 University Drive, Suite 400, Newtown, PA, USA, 18940
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
Executives
Martin J Wygod director P.O. BOX 676306, RANCHO SANTA FE CA 92067
Trotman Stanley S Jr director
Max C Wygod director, officer: Executive Chairman 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Max Wygod Family Dynasty Trust 10 percent owner 41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940
Michael Vesey officer: Chief Financial Officer 4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080
Jennifer Hajj director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Kristiina Md Vuori director C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011
Scott Matthew Ogur director C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231
Farren Clifford A Jr officer: Chief Financial Officer C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326
Adler Mark J Md director
Ian Banwell director P.O. BOX 34004, CHARLOTTE NC 28234
Shahir Kassam-adams director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Adam H Dublin director, officer: Chief Strategy Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Daniel J Barton director, officer: Chief Executive Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Alyssa F Varadhan director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940